Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Department of Applied Mathematics, School of Mathematics, University of Leeds, Leeds, United Kingdom.
Elife. 2021 Apr 19;10:e66014. doi: 10.7554/eLife.66014.
Cytokines elicit pleiotropic and non-redundant activities despite strong overlap in their usage of receptors, JAKs and STATs molecules. We use IL-6 and IL-27 to ask how two cytokines activating the same signaling pathway have different biological roles. We found that IL-27 induces more sustained STAT1 phosphorylation than IL-6, with the two cytokines inducing comparable levels of STAT3 phosphorylation. Mathematical and statistical modeling of IL-6 and IL-27 signaling identified STAT3 binding to GP130, and STAT1 binding to IL-27Rα, as the main dynamical processes contributing to sustained pSTAT1 levels by IL-27. Mutation of Tyr613 on IL-27Rα decreased IL-27-induced STAT1 phosphorylation by 80% but had limited effect on STAT3 phosphorgylation. Strong receptor/STAT coupling by IL-27 initiated a unique gene expression program, which required sustained STAT1 phosphorylation and IRF1 expression and was enriched in classical Interferon Stimulated Genes. Interestingly, the STAT/receptor coupling exhibited by IL-6/IL-27 was altered in patients with systemic lupus erythematosus (SLE). IL-6/IL-27 induced a more potent STAT1 activation in SLE patients than in healthy controls, which correlated with higher STAT1 expression in these patients. Partial inhibition of JAK activation by sub-saturating doses of Tofacitinib specifically lowered the levels of STAT1 activation by IL-6. Our data show that receptor and STATs concentrations critically contribute to shape cytokine responses and generate functional pleiotropy in health and disease.
细胞因子尽管在受体、JAK 和 STAT 分子的使用上有很强的重叠,但却表现出多效性和非冗余的活性。我们使用 IL-6 和 IL-27 来探讨两种激活相同信号通路的细胞因子如何具有不同的生物学作用。我们发现,IL-27 诱导的 STAT1 磷酸化比 IL-6 更持久,两种细胞因子诱导的 STAT3 磷酸化水平相当。对 IL-6 和 IL-27 信号的数学和统计建模确定了 STAT3 与 GP130 的结合,以及 STAT1 与 IL-27Rα 的结合,是 IL-27 诱导持续 pSTAT1 水平的主要动力学过程。IL-27Rα 上 Tyr613 的突变使 IL-27 诱导的 STAT1 磷酸化减少了 80%,但对 STAT3 磷酸化的影响有限。IL-27 强烈的受体/STAT 偶联启动了一个独特的基因表达程序,该程序需要持续的 STAT1 磷酸化和 IRF1 表达,并富含经典的干扰素刺激基因。有趣的是,系统性红斑狼疮(SLE)患者中 IL-6/IL-27 的 STAT/受体偶联发生了改变。与健康对照组相比,SLE 患者中 IL-6/IL-27 诱导的 STAT1 激活更为强烈,这与这些患者中 STAT1 表达升高有关。用亚饱和剂量的托法替尼部分抑制 JAK 激活,特异性降低了 IL-6 诱导的 STAT1 激活水平。我们的数据表明,受体和 STATs 的浓度对塑造细胞因子反应和在健康和疾病中产生功能性多效性至关重要。